SCHEMBL29789762

SCHEMBL29789762

Cn1ccnc1-c1cccc2c1C=CC(C)(C)N2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 1/20 0.38
▸ KDM1A O60341 1/20 0.37
▸ ADRA1D P25100 1/20 0.36
▸ ADRA1A P35348 1/20 0.36
▸ ADRA1B P35368 1/20 0.36
▸ HTR2C P28335 2/20 0.35
▸ HTR2A P28223 1/20 0.35
▸ MC4R P32245 2/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ HSD17B10 Q99714 2/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ KDM4E B2RXH2 2/20 0.34
▸ L3MBTL1 Q9Y468 2/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ PGR P06401 1/20 0.33
▸ CASP1 P29466 1/20 0.32
▸ CASP7 P55210 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23123492 1.00 BRD4 (0.38) BRD4KDM1AADRA1DADRA1AADRA1B
SCHEMBL23123529 0.74 PGR (0.37) BRD4KDM1AALDH1A1HSD17B10CYP3A4
SCHEMBL29790013 0.74 PGR (0.37) BRD4KDM1AALDH1A1HSD17B10CYP3A4
SCHEMBL23123280 0.71 CCNC (0.34) BRD4PGRBACE1BACE2
SCHEMBL29789803 0.71 CCNC (0.34) BRD4PGRBACE1BACE2
SCHEMBL23123822 0.70 KDM1A (0.41) BRD4KDM1AADRA1DADRA1AADRA1B
SCHEMBL29789643 0.70 KDM1A (0.41) BRD4KDM1AADRA1DADRA1AADRA1B
SCHEMBL29789784 0.67 SLC6A4 (0.42) KDM1AHSD17B10KDM4EL3MBTL1
SCHEMBL23123294 0.67 SLC6A4 (0.42) KDM1AHSD17B10KDM4EL3MBTL1
Hydrochloric Acid SCHEMBL4345829 0.66 BRD4 (0.57) BRD4ADRA1DADRA1AADRA1BHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114901652-A Substituted saturated and unsaturated N-heterocyclic carboxamides and related compounds for the treatment of medical disorders 比亚尔R&D投资股份公司 2022-08-12 — — CN disclosed
EP-4031540-A1 SUBSTITUTED, SATURATED AND UNSATURATED N-HETEROCYCLIC CARBOXAMIDES AND RELATED COMPOUNDS FOR THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS Bial-R&D Investments, S.A. (PT) 2022-07-27 — — EP disclosed
Send feedback